Drug Channels

Expert insights by Dr. Adam J. Fein on pharmaceutical economics and the drug distribution system (RSS feed)

 

Drug Channels News Roundup, January 2026: Cuban vs. Optum, McKesson’s Biosimilar Play, States vs. Accumulators, 340B Windfalls, and Ozempic Ads
2026-01-27 11:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.)

Super Bowl LX is almost here! Time for some blowout beer and snack commercials, occasionally interrupted by an actual football game. DCI’s hometown Philadelphia Eagles will not be going to the big game, so the city’s light poles will remain Crisco-free and upright.

While you wait for kickoff, please enjoy this month’s playbook of articles, intercepted for you from the Drug Channels gridiron: Plus: Will Ozempic's new ad campaign make us nostalgic for 2006?

P.S. Join my more than 67,000 LinkedIn followers for daily links to neat stuff, along with sharp, thoughtful commentary from the DCI community.
Read more »
       

 

Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative.